These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10513641)

  • 21. Influence of L-lysine amino acid on the HIV-1 RNA replication in vitro.
    Butorov EV
    Antivir Chem Chemother; 2015 Feb; 24(1):39-46. PubMed ID: 26149265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Storage and Transportation of "HIV" RNA in Plasma Samples up to 45°C in a Lyophilized Stabilizer.
    Weidner J; Hünger F; Odaibo G; Olaleye D; Reichelt D; Greve B; Cassens U
    Clin Lab; 2019 Aug; 65(8):. PubMed ID: 31414752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. gp120-directed antibody-dependent cellular cytotoxicity as a major determinant of the rate of decline in CD4 percentage in HIV-1 disease.
    Skowron G; Cole BF; Zheng D; Accetta G; Yen-Lieberman B
    AIDS; 1997 Dec; 11(15):1807-14. PubMed ID: 9412698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of CD8 lymphocyte activation with cellular viremia and plasma HIV RNA levels in asymptomatic patients infected by human immunodeficiency virus type 1.
    Bouscarat F; Levacher-Clergeot M; Dazza MC; Strauss KW; Girard PM; Ruggeri C; Sinet M
    AIDS Res Hum Retroviruses; 1996 Jan; 12(1):17-24. PubMed ID: 8825614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum HIV-1 p24 antibody, HIV-1 RNA copy number and CD4 lymphocyte percentage are independently associated with risk of mortality in HIV-1-infected children. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.
    Mofenson LM; Harris DR; Rich K; Meyer WA; Read JS; Moye J; Nugent RP; Korelitz J; Bethel J; Pahwa S
    AIDS; 1999 Jan; 13(1):31-9. PubMed ID: 10207542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significant decrease of the enhancement/neutralization index in HIV patients during highly active antiretroviral therapy (HAART).
    Bánhegyi D; Bácsi A; Tóth FD; Prohászka Z; Horváth A; Beck Z; Kónya J; Füst G
    Immunol Lett; 2003 Oct; 89(1):25-30. PubMed ID: 12946861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors for non- and slow progression in human immunodeficiency virus (HIV) type 1 infection: low viral RNA copy numbers in serum and maintenance of high HIV-1 p24-specific but not V3-specific antibody levels.
    Hogervorst E; Jurriaans S; de Wolf F; van Wijk A; Wiersma A; Valk M; Roos M; van Gemen B; Coutinho R; Miedema F
    J Infect Dis; 1995 Apr; 171(4):811-21. PubMed ID: 7706807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV-1 IgA specific serum antibodies and disease progression during HIV-1 infection.
    Margalith M; Levy E; Rinaldo CR; Detels R; Phair J; Kaslow R; Saah AJ; Sarov B
    J Hum Virol; 2001; 4(5):269-77. PubMed ID: 11907384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased adhesion as a mechanism of antibody-dependent and antibody-independent complement-mediated enhancement of human immunodeficiency virus infection.
    Lund O; Hansen J; Søorensen AM; Mosekilde E; Nielsen JO; Hansen JE
    J Virol; 1995 Apr; 69(4):2393-400. PubMed ID: 7884885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ARCHITECT® HIV Ag/Ab Combo assay: correlation of HIV-1 p24 antigen sensitivity and RNA viral load using genetically diverse virus isolates.
    Brennan CA; Yamaguchi J; Vallari A; Swanson P; Hackett JR
    J Clin Virol; 2013 Jun; 57(2):169-72. PubMed ID: 23485348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of plasma viremia with HIV-1 RNA levels in cervicovaginal lavage secretions in HIV-1 seropositive ART naïve women from Pune, India.
    Khopkar P; Sane S; Bichare S; Verma A; Kulkarni S
    J Clin Virol; 2013 Dec; 58(4):730-2. PubMed ID: 24238888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two parallel routes of the complement-mediated antibody-dependent enhancement of HIV-1 infection.
    Prohászka Z; Nemes J; Hidvégi T; Tóth FD; Kerekes K; Erdei A; Szabó J; Ujhelyi E; Thielens N; Dierich MP; Späth P; Ghebrehiwet B; Hampl H; Kiss J; Arlaud G; Füst G
    AIDS; 1997 Jul; 11(8):949-58. PubMed ID: 9223728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebrospinal fluid HIV-1 RNA levels in asymptomatic patients with early stage chronic HIV-1 infection: support for the hypothesis of local virus replication.
    García F; Niebla G; Romeu J; Vidal C; Plana M; Ortega M; Ruiz L; Gallart T; Clotet B; Miró JM; Pumarola T; Gatell JM
    AIDS; 1999 Aug; 13(12):1491-6. PubMed ID: 10465072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of two commercially available, inexpensive alternative assays used for assessing viral load in a cohort of human immunodeficiency virus type 1 subtype C-infected patients from South Africa.
    Stevens G; Rekhviashvili N; Scott LE; Gonin R; Stevens W
    J Clin Microbiol; 2005 Feb; 43(2):857-61. PubMed ID: 15695692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Detection of the viral load and its use as a virological marker in the follow-up of HIV-1-positive patients].
    Hodara VL; Monticelli A; Benetucci J; Lasala M; Jauregui Rueda H; Libonatti O; García Messina O; Reboredo G; Bogdanowicz E; Bases O; Pampuro S; Salomón H
    Rev Argent Microbiol; 1998; 30(1):1-7. PubMed ID: 9629601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Traitors of the immune system-enhancing antibodies in HIV infection: their possible implication in HIV vaccine development.
    Beck Z; Prohászka Z; Füst G
    Vaccine; 2008 Jun; 26(24):3078-85. PubMed ID: 18241961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro antibody-dependent enhancement assays are insensitive indicators of in vivo vaccine enhancement of equine infectious anemia virus.
    Raabe ML; Issel CJ; Montelaro RC
    Virology; 1999 Jul; 259(2):416-27. PubMed ID: 10388665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men.
    Sterling TR; Vlahov D; Astemborski J; Hoover DR; Margolick JB; Quinn TC
    N Engl J Med; 2001 Mar; 344(10):720-5. PubMed ID: 11236775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV-specific CD4-induced Antibodies Mediate Broad and Potent Antibody-dependent Cellular Cytotoxicity Activity and Are Commonly Detected in Plasma From HIV-infected humans.
    Williams KL; Cortez V; Dingens AS; Gach JS; Rainwater S; Weis JF; Chen X; Spearman P; Forthal DN; Overbaugh J
    EBioMedicine; 2015 Oct; 2(10):1464-77. PubMed ID: 26629541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection.
    Fiebig EW; Wright DJ; Rawal BD; Garrett PE; Schumacher RT; Peddada L; Heldebrant C; Smith R; Conrad A; Kleinman SH; Busch MP
    AIDS; 2003 Sep; 17(13):1871-9. PubMed ID: 12960819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.